Back to search

United States· US:58411-967_4a022a9b-8600-bbfc-e063-6394a90a8404

cle de peau BEAUTE PORE-REFINING MATTIFYING VEIL

A medicinal product containing avobenzone; octinoxate; octisalate; octocrylene, registered in United States by Shiseido Americas Corporation.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedcle de peau BEAUTE PORE-REFINING MATT…ATC—REGISTER NO.US:58411-967_4a022a9b…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE
Manufacturer
Shiseido Americas Corporation
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5841196760
    1 TUBE in 1 BOX (58411-967-60) / 38 mL in 1 TUBE
  • ndc11
    58411-967-60

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Avobenzone; octinoxate; octisalate; octocrylene in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All avobenzone; octinoxate; octisalate; octocrylene products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6571ad93-69fe-419f-a834-7e36814813d1
GET /v1/drugs/6571ad93-69fe-419f-a834-7e36814813d1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": ".96995; 2.871052; 1.9399; 1.11394",
  "substance": "AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE",
  "productndc": "58411-967",
  "dosage_form": "PASTE",
  "dea_schedule": null,
  "strength_unit": "g/38mL; g/38mL; g/38mL; g/38mL",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about avobenzone; octinoxate; octisalate; octocrylene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.